Anaemia is an independent predictor of poor outcome in patients with chronic heart failure
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
Background Mild anaemia frequently occurs in patients with chronic heart failure (CHF), particularly in the advanced stages of the disease. The correction of anaemia with erythropoietin is a therapeutic possibility. The aim of this study was to assess prospectively the relationship between the prevalence of anaemia (haemoglobin level<or=120 g/l) and prognosis in an unselected CHF population.Methods All consecutive patients with a diagnosis of CHF admitted to our department between January 2000 and April 2000 were considered for the present study. Those with secondary causes of anaemia were excluded. Patients were followed up until November 2001 (>18 months in all survivors), and the end-point of the study was all-cause mortality.Results A total of 176 patients were enrolled (mean age: 63 years, New York Heart Association (NYHA) classification I/II/III/IV: 15/81/51/29; left ventricular ejection fraction (LVEF): 42%, ischaemic aetiology in 62%). In the whole population the mean haemoglobin level was 140+/-15 g/l. Anaemia was found in 18 (10%) patients, and was significantly more common in women than in men (18 vs. 7%, respectively, P=0.02) and in those with most severe CHF symptoms (frequency in NYHA I/II/III/IV: 0/9/10/21%, respectively; NYHA IV vs. I-III, P=0.03), but not related to the other clinical indices. Univariate analysis revealed NYHA class III-IV (hazard ratio 3.8, 95% CI: 1.6-8.9, P=0.003), low LVEF <35% (hazard ratio 2.3, 95% CI: 1.0-4.9, P=0.04) and anaemia (hazard ratio 2.9, 95% CI: 1.2-7.2, P=0.02) as predictors of 18-month mortality. In multivariate analysis, anaemia remained an independent predictor of death when adjusted for NYHA class and LVEF (hazard ratio: 2.6, 95% CI: 1.0-6.5, P=0.04). In anaemic patients, 18-month survival was 67% (95% CI: 45-89%) compared to 87% (81-92%) in patients with a normal haemoglobin level (P=0.016).Conclusions Mild anaemia is a significant and independent predictor of poor outcome in unselected patients with CHF. Correction of low haemoglobin level may become an interesting therapeutic option for CHF patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of anaemia and/or ID is associated with a poor outcome in patients with CHF 6 , 7 , 8 , 9 , 10 , 11”
From Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure (2020) · cites this paper as [6]
In the citing paper
“Our finding that anaemia is associated with a worse outcome in patients with HF are well in line with earlier studies. 6 , 7 , 8”
From Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure (2020) · cites this paper as [6]
Citations
Cites
Rich, M. W., Beckham, V., Wittenberg, C., Leven, C. L., Freedland, K. E., & Carney, R. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331806 · Cited by 2,328
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Wasting as independent risk factor for mortality in chronic heart failure
Anker, S. D., Ponikowski, P., Varney, S., Chua, T. P., Clark, A. L., Webb-Peploe, K. M., Harrington, D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07015-8 · Cited by 1,399
Self-citationThe impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 769
Silverberg, D. S., Wexler, D., Blum, M., Keren, G., Sheps, D., Leibovitch, E., Brosh, D., Laniado, S., Schwartz, D., Yachnin, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00613-6 · Cited by 728
Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., & Borenstein, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01854-5 · Cited by 712
Al-Ahmad, A., Rand, W. M., Manjunath, G., Konstam, M. A., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01470-x · Cited by 701
Silverberg, D. S., Wexler, D., Sheps, D., Blum, M., Keren, G., Baruch, R., Schwartz, D., Yachnin, T., Steinbruch, S., Shapira, I., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01248-7 · Cited by 644
Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up
Gagnon, D. R., Zhang, T.-J., Brand, F. N., & Kannel, W. B. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90679-3 · Cited by 376
Research works printed but not linked: 1
- Mancini, 2001, Erythropoietin improves exercise capacity in patients with heart failure, Circulation, 104, II-438
Cited by
Anemia and Mortality in Heart Failure Patients
Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.061 · Cited by 764
Iron deficiency: an ominous sign in patients with systolic chronic heart failure
Jankowska, E. A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., Banasiak, W., Polonski, L., Filippatos, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq158 · Cited by 652
Self-citationGo, A. S., Yang, J., Ackerson, L. M., Lepper, K., Robbins, S., Massie, B. M., & Shlipak, M. G. (2006) · Circulation · doi:10.1161/circulationaha.105.577577 · Cited by 515
Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options
Tang, Y.-D., & Katz, S. D. (2006) · Circulation · doi:10.1161/circulationaha.105.583666 · Cited by 415
Toblli, J. E., Lombraña, A., Duarte, P., & Di Gennaro, F. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.029 · Cited by 415
Metadata
- Authors
- Szachniewicz, J., Petruk-Kowalczyk, J., Majda, J., Kaczmarek, A., Reczuch, K., Kalra, P. R., Piepoli, M. F., Anker, S. D., Banasiak, W., & Ponikowski, P.
- Affiliations
- 4. Wojskowy Szpital Kliniczny z Polikliniką (PL)
- Imperial College London (GB)
- Max Delbrück Center (DE)
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 90
- Issue
- 2-3
- Pages
- 303-308
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W2122537544
- Cited by
- 138
- References
- 26
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 2 · 2014: 7 · 2013: 6 · 2012: 3
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- International Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- anemia, chronic heart failure, all-cause mortality, prognostic factors, hemoglobin levels, NYHA functional class, left ventricular ejection fraction, survival, erythropoietin therapy, ischemic heart failure, risk stratification, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Analysis of Variance, Anemia, Female, Heart Failure, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Prevalence, Proportional Hazards Models, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. https://app.cochat.ai/papers/10.1016/s0167-5273(02)00574-0
- The paper
- Szachniewicz, J., Petruk-Kowalczyk, J., Majda, J., Kaczmarek, A., Reczuch, K., Kalra, P. R., Piepoli, M. F., Anker, S. D., Banasiak, W., & Ponikowski, P. (2003). Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. International Journal of Cardiology. https://doi.org/10.1016/s0167-5273(02)00574-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.